Bromfenac ophthalmic solution for the treatment of postoperative ocular pain and inflammation: safety, efficacy, and patient adherence.
about
Computational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics.Bromfenac 0.09% bioavailability in aqueous humor, prophylactic effect on cystoid macular edema, and clinical signs of ocular inflammation after phacoemulsification in a Mexican population.A randomized double-masked study to compare the ocular safety, tolerability, and efficacy of bromfenac 0.075% compared with vehicle in cataract surgery subjects.Bromfenac Ophthalmic Solution 0.07%: A Review of Its Use After Cataract Surgery.Nonbiological pharmacotherapies for the treatment of diabetic macular edema.
P2860
Bromfenac ophthalmic solution for the treatment of postoperative ocular pain and inflammation: safety, efficacy, and patient adherence.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Bromfenac ophthalmic solution ...... ficacy, and patient adherence.
@en
type
label
Bromfenac ophthalmic solution ...... ficacy, and patient adherence.
@en
prefLabel
Bromfenac ophthalmic solution ...... ficacy, and patient adherence.
@en
P2093
P2860
P356
P1476
Bromfenac ophthalmic solution ...... ficacy, and patient adherence.
@en
P2093
Bryan Ross
Khoa Hoang
Rajesh K Rajpal
Sachin D Rajpal
P2860
P304
P356
10.2147/PPA.S46667
P407
P577
2014-06-25T00:00:00Z